Article
A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma.
medRxiv · 2025 · Jo, H.; Dalvi, A.; Yang, W.; Morozova, E.; Munoz, S.; Glasgow, S. M.
Key facts
| Title | A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma. |
|---|---|
| First author | Jo, H.; Dalvi, A.; Yang, W.; Morozova, E.; Munoz, S.; Glasgow, S. M. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2024.12.31.630965 |
| Devices mentioned | K040782, K802418 |
| Product codes mentioned | JAK, KIS, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1